Term Category | Assay | Preferred Assay Title | cell line | differentiated cell specimen | gastruloid | organoid | primary cell | reprogrammed cell specimen | tissue | Grand Total |
---|---|---|---|---|---|---|---|---|---|---|
CRISPR screens | in vitro CRISPR screen using flow cytometry | CRISPR FlowFISH screen | 835 | 835 | ||||||
Variant-EFFECTS | 491 | 491 | ||||||||
CRISPR FACS screen | 64 | 70 | 134 | |||||||
cas mediated mutagenesis | SGE | 1.0K | 1.0K | |||||||
in vitro CRISPR screen using single-cell RNA-seq | Perturb-seq | 58 | 173 | 9 | 240 | |||||
TAP-seq | 31 | 31 | ||||||||
scCRISPR screen | 4 | 4 | 8 | |||||||
in vitro CRISPR screen assay | Proliferation CRISPR screen | 45 | 45 | |||||||
CRISPR MACS screen | 9 | 9 | ||||||||
Migration CRISPR screen | 6 | 6 | ||||||||
Parse SPLiT-seq | 2 | 2 | ||||||||
CRISPR screens Total | 2.6K | 177 | 79 | 2.8K | ||||||
gene expression | single-nucleus RNA sequencing assay | 10x multiome | 8 | 47 | 81 | 13 | 644 | 793 | ||
Parse SPLiT-seq | 296 | 296 | ||||||||
10x multiome with MULTI-seq | 31 | 48 | 4 | 11 | 94 | |||||
SHARE-seq | 2 | 2 | ||||||||
single-cell RNA sequencing assay | SHARE-seq | 19 | 95 | 35 | 209 | 57 | 415 | |||
10x multiome with scMito-seq | 38 | 38 | ||||||||
scRNA-seq | 18 | 10 | 3 | 31 | ||||||
Parse SPLiT-seq | 2 | 2 | ||||||||
bulk RNA-seq assay | RNA-seq | 33 | 48 | 36 | 117 | |||||
single cell nascent transcription sequencing | scNT-seq2 | 79 | 79 | |||||||
scNT-seq | 4 | 4 | ||||||||
direct RNA sequencing assay | ONT dRNA | 8 | 8 | |||||||
gene expression Total | 101 | 292 | 4 | 82 | 369 | 13 | 1.0K | 1.9K | ||
chromatin accessibility | single-nucleus ATAC-seq | 10x multiome | 8 | 47 | 81 | 13 | 644 | 793 | ||
10x multiome with MULTI-seq | 31 | 48 | 4 | 11 | 94 | |||||
SHARE-seq | 2 | 2 | ||||||||
scATAC-seq | 1 | 1 | 2 | |||||||
single-cell ATAC-seq | SHARE-seq | 24 | 120 | 35 | 205 | 52 | 436 | |||
10x multiome with scMito-seq | 38 | 38 | ||||||||
10x multiome | 17 | 17 | ||||||||
scATAC-seq | 4 | 1 | 5 | |||||||
bulk assay for transposase-accessible chromatin using sequencing | ATAC-seq | 13 | 24 | 26 | 63 | |||||
chromatin accessibility Total | 85 | 205 | 4 | 82 | 352 | 13 | 709 | 1.4K | ||
protein | flow cytometry assay | VAMP-seq (MultiSTEP) | 144 | 144 | ||||||
VAMP-seq | 40 | 40 | ||||||||
protein Total | 184 | 184 | ||||||||
multiome | single nucleus methylation and chromatin conformation capture sequencing | snM3C-seq | 42 | 4 | 32 | 78 | ||||
single-nucleus methylcytosine and transcriptome sequencing assay | snMCT-seq | 8 | 42 | 50 | ||||||
multiome Total | 42 | 12 | 74 | 128 | ||||||
reporter | massively parallel reporter assay | MPRA | 10 | 38 | 48 | |||||
lentiMPRA | 12 | 15 | 27 | |||||||
electroporated MPRA | 11 | 11 | ||||||||
self-transcribing active regulatory region sequencing assay | SUPERSTARR | 16 | 16 | |||||||
reporter Total | 49 | 53 | 102 | |||||||
3D chromatin structure | Hi-C assay | HiCAR | 6 | 14 | 20 | |||||
Hi-C | 3 | 9 | 12 | |||||||
3D chromatin structure Total | 9 | 23 | 32 | |||||||
DNA binding | transcription factor binding site identification by ChIP-Seq assay | TF ChIP-seq | 2 | 14 | 16 | |||||
histone modification identification by ChIP-Seq assay | Histone ChIP-seq | 2 | 6 | 8 | ||||||
DNA binding Total | 4 | 20 | 24 | |||||||
genetic profiling | whole genome sequencing assay | WGS | 23 | 23 | ||||||
genetic profiling Total | 23 | 23 | ||||||||
no category | spatial transcriptomics | Spatial transcriptomics | 8 | 8 | ||||||
single cell massively parallel reporter assay | MPRA (scQer) | 6 | 6 | |||||||
no category Total | 6 | 8 | 14 | |||||||
DNA methylation | m6A-MTase sequencing assay | ONT Fiber-seq | 8 | 8 | ||||||
DNA methylation Total | 8 | 8 |